Josh Silverman, Ph.D. is the Chief Technology Officer and Founder of Calysta. Dr. Silverman is an experienced biotechnology entrepreneur with a history of successful development of novel technology platforms. Prior to founding Calysta, Dr. Silverman held positions at two public biotechnology companies, Maxygen, Inc. and Amgen, Inc. as well as serving as VP of Product development for Amunix, Inc. He has been involved in the founding and financing of five startup biotechnology companies (Avidia, Versartis, Diartis, Siluria, and Calysta). His efforts contributed to raising over $110 million in equity financing across these companies, as well as the sale of Avidia for $290M three years after founding the company and an IPO by Versartis in 2014 which raised $126 million. Dr. Silverman is generally interested in tools and applications of biological engineering as a robust and predictable engineering discipline. He serves as an advisor for a number of biotechnology companies and is a frequent speaker at scientific meetings. He has been directly involved in successfully bringing three novel biopharmaceuticals from early phase research into clinical trials, with experience in both regulatory filings and drug manufacturing. He is an author on more than 10 scientific publications as well as over 30 patents and pending patent applications. He received his B.Sc. in Molecular Biology from UC San Diego and Ph.D. in Biochemistry from Stanford University. __________________________________________________________________ URL: http://calysta.com/ Headquartered in: USA Year founded: 2011 Number of employees: 50 Countries where feed is currently distributed: Currently none, but we expect US, UK, Norway, and Japan initially. Type of feed or feed ingredients currently produced: We produce FeedKind protein, a high-protein feed ingredient with properties similar to high-quality fishmeal. FeedKind protein is produced by natural fermentation of methane, a sustainable resource that does not compete with the human food chain, has little to no impact on land or water resources, and does not impact wild fish populations. Creating new ingredients or feeds for F3 Challenge or scaling existing products? Scaling already existing products. We produce an ingredient rather than feeds, so we are currently looking for partners in the feed production space. Registered for F3 alone? Currently, yes. Press contact: Lyn Christensen, lyn@linkagesgroup.com Other information: http://www.theguardian.com/sustainable-business/2016/mar/17/methane-eating-bacteria- reduce-impact- fish-demand- feedkind-calysta http://www.feednavigator.com/Regulation/Carbon-Trust- runs-the- numbers-on- Calysta-s- gas-to-feed-protein http://www.intrafish.com/news/article1439966.ece